黑素瘤原位相关的黑素瘤。
Melanotan-associated melanoma in situ.
机构信息
Department of Dermatology, Churchill Hospital, Oxford, UK.
出版信息
Australas J Dermatol. 2012 Nov;53(4):301-2. doi: 10.1111/j.1440-0960.2012.00915.x. Epub 2012 Jun 22.
Abstract
Injectable synthetic melanotropic peptides (often called melanotan) to enhance tanning are available over the Internet despite being unlicensed compounds with an unproven safety record. There have been reports of dysplastic naevi and melanoma associated with the use of melanotropic peptides. We report a case of melanotan-associated melanoma in situ.
摘要
尽管注射用合成促黑激素（通常称为黑素促黑激素）是未经许可的化合物，且安全性记录未经证实，但仍可通过互联网获得，以增强日晒效果。有报道称使用促黑激素与发育不良痣和黑色素瘤有关。我们报告了一例与黑素促黑激素相关的原位黑色素瘤病例。
相似文献
1
Melanotan-associated melanoma in situ.
Australas J Dermatol. 2012 Nov;53(4):301-2. doi: 10.1111/j.1440-0960.2012.00915.x. Epub 2012 Jun 22.
2
Atypical melanocytic naevi following melanotan injection.
Ir Med J. 2013 May;106(5):148-9.
3
Melanotan-associated melanoma.
Br J Dermatol. 2011 Jun;164(6):1403-5. doi: 10.1111/j.1365-2133.2011.10273.x. Epub 2011 May 13.
4
Eruptive melanocytic naevi following melanotan injection.
Br J Dermatol. 2009 Sep;161(3):707-8. doi: 10.1111/j.1365-2133.2009.09362.x. Epub 2009 Jul 2.
5
Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.
Eur J Dermatol. 2014 Jan-Feb;24(1):107-9. doi: 10.1684/ejd.2013.2227.
6
[Eruptive dysplastic nevi following melanotan use].
Actas Dermosifiliogr. 2012 May;103(4):329-31. doi: 10.1016/j.ad.2011.10.001. Epub 2012 Mar 15.
7
alpha-Melanocyte-stimulating hormone-induced eruptive nevi.
Arch Dermatol. 2009 Apr;145(4):441-4. doi: 10.1001/archdermatol.2008.623.
8
[Melanotan-induced lentigines and nevi].
Ugeskr Laeger. 2011 Mar 28;173(13):975.
9
Melanoma associated with the use of melanotan-II.
Dermatology. 2014;228(1):34-6. doi: 10.1159/000356389. Epub 2013 Dec 18.
10
An in-depth case examination of an exotic dancer's experience of melanotan.
Int J Drug Policy. 2014 May;25(3):444-50. doi: 10.1016/j.drugpo.2013.10.008. Epub 2013 Nov 1.
引用本文的文献
1
An overview of benefits and risks of chronic melanocortin-1 receptor activation.
J Eur Acad Dermatol Venereol. 2025 Jan;39(1):39-51. doi: 10.1111/jdv.20269. Epub 2024 Jul 31.
2
Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma.
J Transl Med. 2023 Aug 22;21(1):562. doi: 10.1186/s12967-023-04405-y.
3
Topical treatment strategies to manipulate human skin pigmentation.
Adv Drug Deliv Rev. 2020 Jan 1;153:65-71. doi: 10.1016/j.addr.2020.02.002. Epub 2020 Feb 21.
4
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.
Clin Pharmacokinet. 2017 Aug;56(8):815-823. doi: 10.1007/s40262-016-0501-5.
5
[Undesirable pigmentation].
Hautarzt. 2015 Oct;66(10):757-63. doi: 10.1007/s00105-015-3671-4.
Zotero 插件